Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice.
about
Antiviral Activity of Resveratrol against Human and Animal VirusesApplication of Traditional Chinese Medical Herbs in Prevention and Treatment of Respiratory Syncytial VirusAntiviral natural products and herbal medicines.Resveratrol plus carboxymethyl-β-glucan in children with recurrent respiratory infections: a preliminary and real-life experienceMMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude miceNeonatal Streptococcus pneumoniae infection may aggravate adulthood allergic airways disease in association with IL-17A.Effective inhibition of MERS-CoV infection by resveratrolHerbal plants and plant preparations as remedial approach for viral diseases.Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunitiesPulmonary C Fibers Modulate MMP-12 Production via PAR2 and Are Involved in the Long-Term Airway Inflammation and Airway Hyperresponsiveness Induced by Respiratory Syncytial Virus InfectionRecent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus.Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survivalResveratrol inhibits the TRIF-dependent pathway by upregulating sterile alpha and armadillo motif protein, contributing to anti-inflammatory effects after respiratory syncytial virus infection.Plant-based modulation of Toll-like receptors: an emerging therapeutic model.Resveratrol, sirtuins, and viruses.Andrographolide Restores Steroid Sensitivity To Block Lipopolysaccharide/IFN-γ-Induced IL-27 and Airway Hyperresponsiveness in Mice.Role of dietary antioxidants in human metapneumovirus infection.Analysis of influence of baicalin joint resveratrol retention enema on the TNF-α, SIgA, IL-2, IFN-γ of rats with respiratory syncytial virus infection.A network flow approach to predict protein targets and flavonoid backbones to treat respiratory syncytial virus infection.Resveratrol Inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells.Antiviral properties of resveratrol against pseudorabies virus are associated with the inhibition of IκB kinase activation.An Interaction of LPS and RSV Infection in Augmenting the AHR and Airway Inflammation in Mice.Respiratory Viral Infections and Subversion of Cellular Antioxidant Defenses.The NS1 protein of Respiratory syncytial virus blocks glucocorticoid receptor nuclear translocation by targeting IPO13 may account for glucocorticoid insensitive.Preventive effect of galectin-9 on double-stranded RNA-induced airway hyperresponsiveness in an exacerbation model of mite antigen-induced asthma in mice.Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae.Vitamin A maintains the airway epithelium in a murine model of asthma by suppressing glucocorticoid-induced leucine zipper.Resveratrol plus carboxymethyl-β-glucan may affect respiratory infections in children with allergic rhinitis.Redox Biology of Respiratory Viral InfectionsAntiviral Effect of Resveratrol in Piglets Infected with Virulent Pseudorabies Virus
P2860
Q26773651-46073364-70C8-4683-95AB-CFEF29DD5139Q28076604-DC48801D-B494-4EC5-A019-2DA194A10D62Q33657624-D3DDD5E8-FD9E-438C-9605-8AC7FB155B9AQ34579112-07A48B13-B586-4443-897C-6249B7CCCDB9Q35096370-7A63650E-D2BB-493A-A6AD-7C3E9FB8D849Q35224875-3FF0771D-1165-472B-8DED-12434A867904Q36279084-3A449D3B-3685-448F-88CA-CBAECFDCFAE5Q36330277-C22DB550-FFEF-4047-9C6B-4AE91864D54DQ36444085-3351279B-6A33-4780-A283-297595C59BCBQ36736876-A5F4E0E0-22DC-48F9-8307-62E8D93924A9Q37412509-CB4D985C-216E-4C0B-A810-32BE2F06EB4FQ37547432-B25652E7-7D84-4724-95DB-82B4CA163DEEQ37713845-615BE1E8-101B-4620-9C00-CD876860A639Q38059461-59DB8A50-3168-4EC7-A205-E206BF8ECE06Q38610855-3A61B122-DCDA-4886-AFBB-91E751E853C7Q38770637-6031EE96-F67B-4E8A-9552-F59E57863471Q38913771-DA7BEBDB-4036-4404-9403-BA2904ACCBA2Q38983722-52A68EFA-C722-4045-91E4-95839A810AC0Q39275749-FF88A90A-5092-4D97-8951-362ED8ECEC7EQ39385125-E6D1398F-24A7-44FB-B234-FD8F6105295AQ40087495-DC667699-2522-458E-A811-39B85E82255BQ40127957-E7928E17-F7ED-40F2-A0F1-74E7A21C4DEEQ41547274-C7804988-C9E5-4CD7-B90F-F7456D56867CQ41926470-B0C215E6-FB74-48B5-A117-192C19718F41Q42254817-B42E360B-D320-48C1-862C-D2B6D6C14ED5Q42379026-560EC6FA-A138-4505-8972-26B14BCB0A51Q50980325-1BCC3755-AD78-412F-B02C-9DFEF820B001Q51698980-4085A595-182A-438C-9A81-B772FBA367F0Q56967921-48CBD0E5-8B7E-4D86-9695-F8FCBFC3BF43Q58700119-F19868C0-96C9-4067-BA53-79C3FACEDA2F
P2860
Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Resveratrol-mediated gamma int ...... fected immunocompromised mice.
@ast
Resveratrol-mediated gamma int ...... fected immunocompromised mice.
@en
type
label
Resveratrol-mediated gamma int ...... fected immunocompromised mice.
@ast
Resveratrol-mediated gamma int ...... fected immunocompromised mice.
@en
prefLabel
Resveratrol-mediated gamma int ...... fected immunocompromised mice.
@ast
Resveratrol-mediated gamma int ...... fected immunocompromised mice.
@en
P2093
P2860
P356
P1433
P1476
Resveratrol-mediated gamma int ...... fected immunocompromised mice.
@en
P2093
Caijing Peng
Lijia Wang
Shengde Wu
Xiaohong Xie
P2860
P304
13061-13068
P356
10.1128/JVI.05869-11
P407
P577
2011-09-21T00:00:00Z